Xiangyu Medical Co.,Ltd (SHA:688626)

Xiangyu Medical Co.,Ltd Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	743.53	736.61	483.87	515.8	491.24
Other Revenue	-	8.2	4.66	7.7	4.27
Revenue	743.53	744.81	488.53	523.5	495.51
Revenue Growth (YoY)	-0.17%	52.46%	-6.68%	5.65%	15.93%
Cost of Revenue	-	243.35	170.08	169.57	162.69
Gross Profit	743.53	501.46	318.44	353.92	332.82
Selling, General & Admin	-	210.41	175.89	140.42	113.99
Research & Development	-	106.75	92.41	68.61	51.55
Other Operating Expenses	634.82	-9	-3.6	0.55	2.88
Operating Expenses	634.82	310.31	264.77	211.78	170.12
Operating Income	108.71	191.15	53.67	142.15	162.7
Interest Expense	-	-2.78	-0.19	-	-0.17
Interest & Investment Income	-	38.82	37.59	33.73	11.64
Currency Exchange Gain (Loss)	-	0.02	0.02	-0.02	0.06
Other Non Operating Income (Expenses)	-1.28	2.5	2.61	2.16	1.1
EBT Excluding Unusual Items	107.44	229.72	93.7	178.02	175.33
Gain (Loss) on Sale of Investments	-	-3.24	-1.06	-	-0.31
Gain (Loss) on Sale of Assets	-	0.01	-	-0.01	0.01
Asset Writedown	-	-0.02	-0.25	-	-0.14
Other Unusual Items	-	17.55	40.6	44.72	47.9
Pretax Income	107.44	244.03	132.99	222.72	222.79
Income Tax Expense	3.94	15.72	9.7	23.18	26.78
Earnings From Continuing Operations	103.49	228.31	123.3	199.54	196.01
Minority Interest in Earnings	-	-1.17	2.17	2.36	0.25
Net Income	103.49	227.14	125.47	201.9	196.26
Net Income to Common	103.49	227.14	125.47	201.9	196.26
Net Income Growth	-54.44%	81.03%	-37.85%	2.87%	52.17%
Shares Outstanding (Basic)	157	158	159	150	120
Shares Outstanding (Diluted)	157	158	159	150	120
Shares Change (YoY)	-0.59%	-0.68%	6.20%	24.97%	-0.72%
EPS (Basic)	0.66	1.44	0.79	1.35	1.64
EPS (Diluted)	0.66	1.44	0.79	1.35	1.64
EPS Growth	-54.17%	82.28%	-41.48%	-17.68%	53.27%
Free Cash Flow	-	-251.35	-16.37	31.97	76.69
Free Cash Flow Per Share	-	-1.59	-0.10	0.21	0.64
Dividend Per Share	-	0.530	0.240	0.380	0.370
Dividend Growth	-	120.90%	-36.84%	2.70%	-
Gross Margin	100.00%	67.33%	65.18%	67.61%	67.17%
Operating Margin	14.62%	25.66%	10.99%	27.15%	32.84%
Profit Margin	13.92%	30.50%	25.68%	38.57%	39.61%
Free Cash Flow Margin	-	-33.75%	-3.35%	6.11%	15.48%
EBITDA	125.65	208.09	69.74	153.52	173.48
EBITDA Margin	16.90%	27.94%	14.27%	29.33%	35.01%
D&A For EBITDA	16.93	16.93	16.06	11.37	10.78
EBIT	108.71	191.15	53.67	142.15	162.7
EBIT Margin	14.62%	25.66%	10.99%	27.15%	32.84%
Effective Tax Rate	3.67%	6.44%	7.29%	10.41%	12.02%
Revenue as Reported	-	744.81	488.53	523.5	495.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.